Related Experiment Videos

T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses

Jane Marttila1, Heikki Hyöty, Pekka Vilja

  • 1JDRF Center for Prevention of Type 1 Diabetes in Finland, Department of Virology, University of Turku, Turku, Finland. jane.marttila@utu.fi

Virology
|March 12, 2002
PubMed

Insights

This study mapped T cell epitopes in Coxsackievirus B4 (CBV4) structural proteins, identifying conserved regions in VP4 and VP2. These findings are crucial for developing effective synthetic vaccines against CBV4 infections.

Area of Science:

  • Virology
  • Immunology
  • Vaccine Development

Background:

  • Coxsackievirus B4 (CBV4) is a significant human pathogen.
  • Understanding T cell responses to CBV4 is vital for vaccine design.
  • Epitope mapping is essential for identifying key targets for immune stimulation.

Purpose of the Study:

  • To systematically characterize T cell target epitopes within CBV4 structural proteins.
  • To identify conserved immunogenic regions for potential vaccine development.
  • To investigate the influence of HLA-DR genotype on T cell epitope recognition.

Main Methods:

  • Synthesis of 86 overlapping 20-amino acid peptides covering CBV4 structural proteins.
  • Analysis of T cell proliferation responses from 18 CBV4-specific T cell lines against synthesized peptides.
  • Statistical analysis (Fisher's exact test) to compare recognition of conserved versus variable regions.

Main Results:

  • Peptide recognition varied significantly based on the donor's HLA-DR genotype.
  • Identified immunodominant epitopes concentrated in the VP4 and VP2 protein regions.
  • Conserved peptide regions were recognized more frequently (15%) than variable regions (3%) by T cell lines.

Conclusions:

  • The VP4 and VP2 regions of CBV4 contain critical T cell epitopes.
  • Conserved epitopes within CBV4 structural proteins are key targets for T cell responses.
  • This knowledge can guide the rational design of novel CBV4 synthetic vaccines.

Related Concept Videos